SE8701479L - Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav - Google Patents

Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav

Info

Publication number
SE8701479L
SE8701479L SE8701479A SE8701479A SE8701479L SE 8701479 L SE8701479 L SE 8701479L SE 8701479 A SE8701479 A SE 8701479A SE 8701479 A SE8701479 A SE 8701479A SE 8701479 L SE8701479 L SE 8701479L
Authority
SE
Sweden
Prior art keywords
biologically effective
containing biologically
effective preparations
active substance
biologically active
Prior art date
Application number
SE8701479A
Other languages
English (en)
Swedish (sv)
Other versions
SE8701479D0 (sv
Inventor
U Schroeder
Original Assignee
Carbomatrix Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carbomatrix Ab filed Critical Carbomatrix Ab
Priority to SE8701479A priority Critical patent/SE8701479L/
Publication of SE8701479D0 publication Critical patent/SE8701479D0/xx
Priority to PCT/SE1988/000183 priority patent/WO1988007870A1/en
Publication of SE8701479L publication Critical patent/SE8701479L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
SE8701479A 1987-04-09 1987-04-09 Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav SE8701479L (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE8701479A SE8701479L (sv) 1987-04-09 1987-04-09 Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav
PCT/SE1988/000183 WO1988007870A1 (en) 1987-04-09 1988-04-11 A method for entrapment of biologically active substances and the use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8701479A SE8701479L (sv) 1987-04-09 1987-04-09 Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav

Publications (2)

Publication Number Publication Date
SE8701479D0 SE8701479D0 (sv) 1987-04-09
SE8701479L true SE8701479L (sv) 1988-10-10

Family

ID=20368147

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8701479A SE8701479L (sv) 1987-04-09 1987-04-09 Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav

Country Status (2)

Country Link
SE (1) SE8701479L ( )
WO (1) WO1988007870A1 ( )

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ244147A (en) † 1991-09-03 1994-09-27 Hoechst Ag Echogenic particles which comprise a gas and at least one shaping substance, and their use as diagnostic agents
DE69220317T2 (de) * 1991-10-01 1997-10-16 Takeda Chemical Industries Ltd Mikropartikeln-Zusammenfassung zur verlängerten Freigabe und Herstellung derselbe
AU1702395A (en) * 1994-02-17 1995-09-04 Pankaj Modi Drugs, vaccines and hormones in polylactide coated microspheres
KR100201352B1 (ko) * 1995-03-16 1999-06-15 성재갑 단일주사 백신 제형
SE505146C2 (sv) * 1995-10-19 1997-06-30 Biogram Ab Partiklar för fördröjd frisättning
AU5719798A (en) * 1996-12-31 1998-07-31 Inhale Therapeutic Systems, Inc. Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
FR2778336A1 (fr) * 1998-05-11 1999-11-12 Jean Pierre Perraud Implant injectable en sous-cutane et en sous-gingival resorbable a base de maltodextrine micro-encapsulee et resorbable en un temps determine
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
WO2003037303A1 (en) 2001-11-01 2003-05-08 Nektar Therapeutics Spray drying methods and compositions thereof
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
CA2518475C (en) 2003-03-07 2014-12-23 Alnylam Pharmaceuticals, Inc. Irna agents comprising asymmetrical modifications
EP1620544B1 (en) 2003-04-17 2018-09-19 Alnylam Pharmaceuticals Inc. MODIFIED iRNA AGENTS
CA2522349A1 (en) 2003-04-17 2004-11-04 Alnylam Pharmaceuticals, Inc. Protected monomers
WO2009082607A2 (en) 2007-12-04 2009-07-02 Alnylam Pharmaceuticals, Inc. Targeting lipids
WO2009126933A2 (en) 2008-04-11 2009-10-15 Alnylam Pharmaceuticals, Inc. Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
WO2011109427A2 (en) 2010-03-01 2011-09-09 Alnylam Pharmaceuticals, Inc. Improving the biological activity of sirna through modulation of its thermodynamic profile
MX350838B (es) 2011-02-11 2017-09-18 Grain Proc Corporation * Composicion de sal.
US20170304459A1 (en) 2014-10-10 2017-10-26 Alnylam Pharmaceuticals, Inc. Methods and compositions for inhalation delivery of conjugated oligonucleotide

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE640616A ( ) * 1962-12-19
GB1468172A (en) * 1973-03-28 1977-03-23 Benzon As Alfred Oral drug preparations
US4273920A (en) * 1979-09-12 1981-06-16 Eli Lilly And Company Polymerization process and product
SE8204244L (sv) * 1982-07-09 1984-01-10 Ulf Schroder Kristalliserad kolhydratsmatris for biologiskt aktiva substanser
US4479911A (en) * 1982-01-28 1984-10-30 Sandoz, Inc. Process for preparation of microspheres and modification of release rate of core material
US4530840A (en) * 1982-07-29 1985-07-23 The Stolle Research And Development Corporation Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
FR2557459B1 (fr) * 1984-01-02 1986-05-30 Lhd Lab Hygiene Dietetique Matrice inerte a base de polycaprolactone pour administration orale d'un medicament, et procede de preparation de la forme galenique comprenant cette matrice

Also Published As

Publication number Publication date
SE8701479D0 (sv) 1987-04-09
WO1988007870A1 (en) 1988-10-20

Similar Documents

Publication Publication Date Title
SE8701479D0 (sv) Metod for inneslutning av biologiskt verksamma preparat samt anvendning derav
ATE68343T1 (de) Darreichungsform mit kontrollierter freigabe.
NO891052L (no) Farmaseutisk produkt for styrt avgivelse.
DE3868037D1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
NO904754L (no) Kapsel for innkapsling av biologisk aktive materialer, fremgangsmaate for fremstilling av denne, samt anvendelse derav.
ATE112961T1 (de) Cimetidin enthaltende arzneimittel.
SE8504720L (sv) Ny lekemedelsberedning
DE68928034T2 (de) Protein mit zeitverabreichung
NO882406D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive urinstoff- og karbamat-forbindelser.
DE68905613D1 (de) Pharmazeutische zubereitung.
NO921603D0 (no) Fremgangsmaate til fremstilling av et aktivt findelt agregat for bruk til betong
NO933237D0 (no) Absorbat av en hjelpestoffblanding og et ikke-fast virksomt stoff for fremstilling av legemiddelpreparater
MY103627A (en) A controlled release pharmaceutical dosage form and a process for preparing same.
NO173098C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 10-propynol-androstener
AU6322686A (en) Pharmaceutical formulations with controlled release of the active substance
NO890502D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etanolamin-derivater.
NO891678D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etanolamin-derivater.
AU2791295A (en) Method of determining the amount of active substance released from solid or semi-solid preparations administered to humans or animals

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8701479-1

Effective date: 19881216